NO20021827L - Direkte kompresjons-polymer tablettkjerne - Google Patents

Direkte kompresjons-polymer tablettkjerne

Info

Publication number
NO20021827L
NO20021827L NO20021827A NO20021827A NO20021827L NO 20021827 L NO20021827 L NO 20021827L NO 20021827 A NO20021827 A NO 20021827A NO 20021827 A NO20021827 A NO 20021827A NO 20021827 L NO20021827 L NO 20021827L
Authority
NO
Norway
Prior art keywords
tablet core
aliphatic amine
amine polymer
direct compression
approx
Prior art date
Application number
NO20021827A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021827D0 (no
Inventor
Joseph Tyler
John S Petersen
Original Assignee
Geltex Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharma Inc filed Critical Geltex Pharma Inc
Publication of NO20021827D0 publication Critical patent/NO20021827D0/no
Publication of NO20021827L publication Critical patent/NO20021827L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20021827A 1999-10-19 2002-04-18 Direkte kompresjons-polymer tablettkjerne NO20021827L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16025899P 1999-10-19 1999-10-19
US17422700P 2000-01-03 2000-01-03
PCT/US2000/028548 WO2001028527A2 (fr) 1999-10-19 2000-10-13 Noyau de comprime polymere par compression directe

Publications (2)

Publication Number Publication Date
NO20021827D0 NO20021827D0 (no) 2002-04-18
NO20021827L true NO20021827L (no) 2002-05-29

Family

ID=26856737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021827A NO20021827L (no) 1999-10-19 2002-04-18 Direkte kompresjons-polymer tablettkjerne

Country Status (29)

Country Link
EP (1) EP1239837B1 (fr)
JP (4) JP4942271B2 (fr)
KR (1) KR100794427B1 (fr)
CN (1) CN1202812C (fr)
AR (1) AR026067A1 (fr)
AT (1) ATE286386T1 (fr)
AU (1) AU778262B2 (fr)
BG (1) BG106626A (fr)
BR (1) BRPI0015061B8 (fr)
CA (1) CA2387915C (fr)
CZ (1) CZ20021344A3 (fr)
DE (1) DE60017285T2 (fr)
EA (1) EA200200387A1 (fr)
EE (1) EE200200209A (fr)
ES (1) ES2235969T3 (fr)
HK (1) HK1049451B (fr)
HU (1) HUP0203334A2 (fr)
IL (1) IL149146A0 (fr)
IS (1) IS6343A (fr)
MX (1) MXPA02003684A (fr)
MY (1) MY125495A (fr)
NO (1) NO20021827L (fr)
NZ (1) NZ518334A (fr)
PL (1) PL364888A1 (fr)
PT (1) PT1239837E (fr)
SK (1) SK5412002A3 (fr)
TR (1) TR200201087T2 (fr)
TW (1) TWI225413B (fr)
WO (1) WO2001028527A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20021344A3 (cs) * 1999-10-19 2002-08-14 Geltex Pharmaceuticals, Inc. Tableta obsahující jádro a potahování a stlačená tableta
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
CA2551528A1 (fr) * 2003-12-31 2005-07-21 Genzyme Corporation Agents sequestrants des acides biliaires a base de polymeres d'amine aliphatique a revetement gastro-resistant
ES2339571T3 (es) 2004-03-30 2010-05-21 Relypsa, Inc. Polimeros de union a potasio y usos de los mismos.
AU2012200480B2 (en) * 2004-11-01 2014-10-16 Genzyme Corporation "Aliphatic amine polymer salts for tableting"
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP2008533170A (ja) * 2005-03-17 2008-08-21 アムジエン・インコーポレーテツド 石灰化減少方法
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
JP5595660B2 (ja) * 2005-09-15 2014-09-24 ジェンザイム コーポレーション アミンポリマー用サシェ製剤
JP2010502590A (ja) * 2006-09-01 2010-01-28 ユーエスヴィー リミテッド セベラマー塩酸塩およびその処方物の調製のためのプロセス
EP2066293A2 (fr) 2006-09-29 2009-06-10 Genzyme Corporation Compositions dendrimères d'amide
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
WO2009034540A1 (fr) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Composition pharmaceutique à base de sevelamer
DE102008030046A1 (de) * 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US20110159087A1 (en) 2008-09-02 2011-06-30 Dhananjay Govind Sathe Crosslinked Polymers
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
ES2350999B1 (es) * 2009-06-26 2011-12-07 Combino Pharm, S.L. Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano).
WO2010149794A2 (fr) 2009-06-26 2010-12-29 Combino Pharm, S.L. Nouvelle composition pharmaceutique comprenant du poly(allylamine-co-n,n'-diallyl-1,3-diamino-2-hydroxypropane)
DK2490675T3 (en) * 2009-10-22 2019-04-29 Synthon Bv Pharmaceutical compositions with sevelamer
EP2545907A1 (fr) 2011-07-15 2013-01-16 Combino Pharm, S.L. Procédé de granulation humide aqueuse pour polymères de polyallylamine réticulés
JP6289367B2 (ja) * 2012-06-05 2018-03-07 武田薬品工業株式会社 有核錠
CN102908325B (zh) * 2012-11-12 2014-07-30 南京生命能科技开发有限公司 一种碳酸司维拉姆药用片剂组合物及其制备方法
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3313710B2 (ja) * 1991-07-03 2002-08-12 ファルマシア・アンド・アップジョン・カンパニー コレスチポール塩酸塩の錠剤化
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
JP3389493B2 (ja) * 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
CZ20021344A3 (cs) * 1999-10-19 2002-08-14 Geltex Pharmaceuticals, Inc. Tableta obsahující jádro a potahování a stlačená tableta

Also Published As

Publication number Publication date
PL364888A1 (en) 2004-12-27
EE200200209A (et) 2003-06-16
NO20021827D0 (no) 2002-04-18
JP4942271B2 (ja) 2012-05-30
SK5412002A3 (en) 2002-09-10
JP5903111B2 (ja) 2016-04-13
HK1049451B (zh) 2005-12-16
BRPI0015061B8 (pt) 2021-05-25
NZ518334A (en) 2003-08-29
AU1088701A (en) 2001-04-30
BRPI0015061B1 (pt) 2016-03-22
ATE286386T1 (de) 2005-01-15
TR200201087T2 (tr) 2002-08-21
TWI225413B (en) 2004-12-21
BG106626A (bg) 2003-03-31
WO2001028527A3 (fr) 2002-01-03
PT1239837E (pt) 2005-05-31
HK1049451A1 (en) 2003-05-16
MY125495A (en) 2006-08-30
HUP0203334A2 (hu) 2003-02-28
IL149146A0 (en) 2002-11-10
CN1382041A (zh) 2002-11-27
ES2235969T3 (es) 2005-07-16
CA2387915A1 (fr) 2001-04-26
MXPA02003684A (es) 2002-08-30
JP5583110B2 (ja) 2014-09-03
KR100794427B1 (ko) 2008-01-16
BR0015061A (pt) 2002-07-23
JP2003512317A (ja) 2003-04-02
IS6343A (is) 2002-04-15
JP2014065749A (ja) 2014-04-17
JP2016000753A (ja) 2016-01-07
EA200200387A1 (ru) 2002-10-31
AR026067A1 (es) 2002-12-26
DE60017285T2 (de) 2005-12-08
WO2001028527A2 (fr) 2001-04-26
JP2012067132A (ja) 2012-04-05
CZ20021344A3 (cs) 2002-08-14
CN1202812C (zh) 2005-05-25
EP1239837A2 (fr) 2002-09-18
DE60017285D1 (de) 2005-02-10
EP1239837B1 (fr) 2005-01-05
KR20020059629A (ko) 2002-07-13
AU778262B2 (en) 2004-11-25
CA2387915C (fr) 2007-04-17

Similar Documents

Publication Publication Date Title
NO20021827L (no) Direkte kompresjons-polymer tablettkjerne
DK0862418T3 (da) Fremgangsmåde til fremstilling af morphologisk ensartede mikrokapsler såvel som mikrokapsler fremstillet efter denne fremgangsmåde
CA2382523A1 (fr) Procede d'optimisation des valeurs de parametres dans un processus de production d'un produit
EP0731448A3 (fr) Techniques de compensation de trames de données perdues
NO972608L (no) Opplösningshjelpemidler for hydrofile makromolekyler
AU2001236905A1 (en) Bioadhesive composition
NO964213D0 (no) Forbedret anti-flass shampo
AU5651686A (en) Process for preparing polymeric particles
ATE37982T1 (de) N-acetyl-p-aminophenol-mittel enthaltend teilweise gelierte staerke sowie verfahren zu deren herstellung.
NO973730L (no) Faste virkestofftilberedninger
NO962699L (no) Selv-dispergerende, herdbare epoksyharpikser og belegg
MX9701839A (es) Proceso para establizar productos de gelatina.
EP0404184A3 (fr) Procédé de préparation de particules polymères contenant des microcavités
ATE149826T1 (de) Verfahren zur herstellung von festen pharmazeutischen retardformen
DK1370243T3 (da) Fremgangsmåde til at opnå mikropartikler, der indeholder en H+,K+-ATPase-inhibitor
DE50000866D1 (de) Verfahren zur herstellung von festen cyclodextrinhaltigen dosierungsformen
DE69616072D1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
KR850001693A (ko) 아모술랄롤 하이드로클로라이드 지속성 제제의 제조방법
DK0749305T3 (da) Fremgangsmåde til fremstilling af avermectin/zein-sammensætninger
NO954858L (no) Fremgangsmåte for fremstilling av en biodegraderbar, hydrofobisk og transparent film og film oppnådd ved fremgangsmåten
ATE220701T1 (de) Verfahren zur herstellung von reaktiven pulverlackzusammensetzungen
DE60328459D1 (de) Polymerisationsverfahren zur herstellung von syndiotaktischem 1,2-polybutadien
AU8403298A (en) Nucleic acid ladders
ES2104363T3 (es) Proceso para la preparacion de acido aminometanofosfonico.
NO974893L (no) Preparat av tyrosin og polymerisert allergen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application